Express News | Achieve Life Sciences To Present Cytisinicline ORCA-V1 Program Data At SGIM Annual Meeting
Buy Rating Affirmed: Achieve Life Sciences' Promising Path to Cytisinicline NDA and Strong Financial Outlook
Buy Rating Affirmed for Achieve Life Sciences Amid Positive Drug Development Progress and Strong Financial Position
Achieve Life Sciences Is Maintained at Outperform by Oppenheimer
Achieve Life Sciences Is Maintained at Outperform by Oppenheimer
Express News | Achieve Life Sciences Inc. : Oppenheimer Cuts Target Price to $11 From $18
Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results
Buy Rating Affirmed for Achieve Life Sciences on Strong Clinical Progress and Solid Financial Footing
Earnings Call Summary | Achieve Life(ACHV.US) Q1 2024 Earnings Conference
The following is a summary of the Achieve Life Sciences, Inc. (ACHV) Q1 2024 Earnings Call Transcript:Financial Performance:Achieve Life Sciences reported having cash, cash equivalents, and restricted
Achieve Life Sciences, Inc. (ACHV) Q1 2024 Earnings Call Transcript
Achieve Life Sciences, Inc. (ACHV) Q1 2024 Earnings Call Transcript
Achieve Life | 10-Q: Quarterly report
Express News | Achieve Life Sciences Q1 Income From Operations USD -5.982 Million Vs. Ibes Estimate USD -6.25 Million
Express News | Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
Express News | Achieve Life Sciences Q1 Operating Expenses USD 5.982 Million
Express News | Achieve Life Sciences Q1 EPS USD -0.26 Vs. Ibes Estimate USD -0.24
Achieve Life Sciences 1Q Loss/Shr 26c >ACHV
Achieve Life Sciences 1Q Loss/Shr 26c >ACHV
Express News | Achieve Announces the Close of $170.1M Heloc Securitization
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Achieve Life Sciences, Inc. (Nasdaq: ACHV) today announced publication of the ORCA-V1 trial results in the Journal of the American Medical Association (JAMA) Internal Medicine.
Express News | Achieve Life Sciences Files Prospectus Related To Offer & Sale From Time To Time Of Up To 13.1M Shares Of Common Stock, By Selling Stockholders
Express News | Achieve Life Sciences- Files Prospectus Related to Offer & Sale From Time to Time of up to 13.1 Mln Shares of Common Stock,by Selling Stockholders
Jones Starts Achieve Life Sciences at Buy, Cites Market Opportunity